Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 13, 2023

BUY
$10.23 - $17.14 $483,469 - $810,036
47,260 Added 4.43%
1,114,111 $12.3 Million
Q4 2022

Jan 23, 2023

BUY
$13.96 - $20.4 $4.73 Million - $6.91 Million
338,487 Added 46.47%
1,066,851 $0
Q3 2022

Oct 26, 2022

BUY
$17.85 - $26.95 $1.76 Million - $2.66 Million
98,610 Added 15.66%
728,364 $13.9 Million
Q2 2022

Jul 25, 2022

BUY
$16.33 - $22.2 $328,330 - $446,353
20,106 Added 3.3%
629,754 $13.4 Million
Q1 2022

May 02, 2022

SELL
$14.38 - $22.79 $114,349 - $181,226
-7,952 Reduced 1.29%
609,648 $11.7 Million
Q4 2021

Jan 28, 2022

BUY
$14.98 - $25.5 $9.25 Million - $15.7 Million
617,600 New
617,600 $12.8 Million

Others Institutions Holding ARQT

About Arcutis Biotherapeutics, Inc.


  • Ticker ARQT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,187,500
  • Market Cap $560M
  • Description
  • Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...
More about ARQT
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.